phone icon (917) 310-3371 Book Aristada Initio evaluation
Nao Medical

Aristada initiation

Aristada Initio Evaluation and Coordination in New York

A one-time initiation medicine used with oral aripiprazole to start or restart Aristada for adult schizophrenia when the responsible prescriber determines it is appropriate.

Aristada Initio is not a recurring maintenance injection and is not interchangeable with Aristada. The current label describes one 675 mg Aristada Initio injection with one 30 mg oral aripiprazole dose in connection with the first Aristada injection. Nao starts with a virtual psychiatric review and confirms the complete prescriber-led sequence before any administration.

Evaluation comes before treatment A virtual psychiatric evaluation comes first. Product, order, delivery, staff, and site are confirmed separately.

The initiation sequence must be treated as one plan

Aristada Initio has a narrow product-specific role. A fragmented order or an assumption that Initio replaces Aristada can create a medication error.

Approved role

Aristada Initio, with oral aripiprazole, initiates Aristada when Aristada is used to treat schizophrenia in adults.

Single labeled dose

The label describes one 675 mg intramuscular Aristada Initio dose and one 30 mg oral aripiprazole dose.

Aristada timing

The first Aristada injection may be given on the same day as Aristada Initio or up to 10 days later under the documented plan.

Not interchangeable

Aristada Initio and Aristada have different pharmacokinetic profiles and cannot be substituted for each other.

How Nao reviews an Aristada Initio request

The evaluation confirms clinical fit and the full initiation order before access or site coordination begins.

1. Confirm the treatment goal

Review the adult schizophrenia diagnosis, prior medicines, response, side effects, adherence, current symptoms, and reason for starting or restarting Aristada.

2. Verify oral aripiprazole history

Document prior tolerability or the prescriber's plan to establish it, plus CYP2D6 status and interacting medicines that can make Initio inappropriate.

3. Match every component

Confirm the oral aripiprazole dose, Aristada Initio order, first Aristada dose, allowed timing, separate injection sites, and responsible prescriber.

4. Coordinate delivery and administration

Confirm benefits, patient-specific delivery, medication arrival, trained staff, administration site, and follow-up before scheduling the injection visit.

What to prepare for the first evaluation

Complete records reduce avoidable delays and help the clinician separate a new decision from continuation of an established plan.

  • The signed orders for Aristada Initio, oral aripiprazole, and Aristada, including doses and intended dates.
  • Documentation of prior oral aripiprazole exposure and tolerability.
  • Current medicines, allergies, CYP2D6 information if known, and recent psychiatric or hospital records.
  • Insurance, specialty-pharmacy, prior authorization, and intended delivery details.

Safety, monitoring, and treatment boundaries

The clinical plan is individualized. These points highlight questions that need explicit review rather than replacing the current label, a full evaluation, or emergency care.

Interaction limits

The label says to avoid Aristada Initio in known CYP2D6 poor metabolizers and with strong CYP2D6 or CYP3A4 inhibitors or strong CYP3A4 inducers.

Separate injection sites

When Initio and Aristada are given on the same day, they should not be injected into the same deltoid or gluteal muscle.

Antipsychotic monitoring

Review movement symptoms, restlessness, weight, glucose, lipids, blood pressure, sedation, impulse-control changes, and pregnancy considerations.

No self-directed restart

A late Aristada dose may have more than one labeled supplementation option. The prescriber must select the correct re-initiation plan.

When to get urgent or emergency help

Get urgent help for high fever with severe muscle stiffness or confusion, fainting, a seizure, trouble breathing, a serious allergic reaction, uncontrolled movements, or immediate safety concerns.

Virtual evaluation first, administration site confirmed later

Start with virtual psychiatry. The team reviews the medicine, order, dose history, delivery, trained staff, and site before scheduling an in-person injection. Do not arrange a shipment or travel to a clinic until the team confirms the plan.

Nao Medical Mineola clinic

Long Island

Mineola

135 Mineola Blvd, Mineola, NY 11501

Start with virtual psychiatry. Nao confirms medication delivery, trained staff, and the administration site before you travel for an injection appointment.

Choose condition-focused care for diagnosis and long-term treatment planning. Choose a medicine-specific service for initiation, access, monitoring, delivery, or administration questions.

Clinical and regulatory sources

These authoritative sources were checked on August 1, 2026. Drug labels and guidance can change, so the treating clinician uses current information for each decision.

Common questions about Aristada Initio

No. Aristada Initio is a one-time initiation medicine and is not interchangeable with recurring Aristada maintenance injections.
The current label describes one 675 mg Aristada Initio injection, one 30 mg oral aripiprazole dose, and the first prescribed Aristada injection as part of the initiation plan.
It may be given on the same day as Aristada Initio or up to 10 days later. The responsible prescriber must document the exact sequence and timing.
If you have never taken an aripiprazole product, oral tolerability should be established before Aristada Initio is used.
No. Restart instructions depend on the Aristada dose and time since the last injection. The prescriber must use the current Aristada label to choose the appropriate supplementation plan.
You can book the virtual psychiatric evaluation. The administration visit is confirmed only after the complete plan, order acceptance, medication arrival, trained staff, and eligible site are verified.
Nao can review it. Acceptance depends on complete orders for every component, oral-tolerability documentation, clinical records, a responsible prescriber, delivery, and site capability.
Coverage and prior authorization can differ by plan and benefit channel. The evaluation, both medicines, and administration may require separate review.
Book Aristada Initio evaluation Call with questions

Updated August 1, 2026. This information does not replace an individual medical evaluation. A licensed clinician determines diagnosis, medication eligibility, prescribing, testing, dosing, administration, and follow-up.

Health information notice

General information only. This page is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.

Content was updated August 1, 2026 from the sources cited on this page. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.